Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

GenSight Biologics S.A. - Filing #2813015

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
33,753,000 EUR
17,139,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
172,000 EUR
16,000 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
95,000 EUR
23,739,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.